EpiCypher

EpiCypher is a private, revenue-generating company that has established itself as a key provider of specialized research tools and services in the epigenetics and chromatin biology space. Its core business model combines the sale of proprietary reagent kits and platforms with fee-for-service analytical and custom development work. The company's technology portfolio, including the CUTANA™ assays (CUT&RUN, CUT&Tag) and Fiber-seq, addresses the need for high-resolution, low-input epigenetic profiling, positioning it at the forefront of a growing research market. EpiCypher's strategy is deeply collaborative, engaging in co-authored research to validate and advance its technologies.

Portfolio of epigenomic profiling platforms including CUTANA™ (CUT&RUN, CUT&Tag) assays, SNAP spike-in controls for quantification, Fiber-seq long-read multi-omic mapping, and recombinant nucleosome libraries.

EpiCypher competes in the epigenetics research tools market against large diversified players like Thermo Fisher Scientific, Abcam, and Active Motif, as well as specialized epigenetics companies. Its differentiation lies in its specialized, optimized assay platforms (CUTANA™), unique quantitative standards (SNAP), and cutting-edge long-read technology (Fiber-seq).